The Possibilities of the University of Maryland Center for Translational Engineering and Medicine
The $10 million gift from the Edward St. John Foundation for the Edward and Jennifer St. John Center for Translational Engineering and Medicine (CTEM) will open a world of possibilities for collaboration between the University of Maryland School of Medicine in Baltimore and the A. James Clark School of Engineering in College Park.CTEM is led by co-directors Giuliano Scarcelli, PhD, of the Fischell Department of Bioengineering in the A. James Clark School of Engineering at UMCP, and Osamah J. Saeedi, MD, of the Department of Ophthalmology and Visual Sciences at UMSOM.Their collaborative work using cutting-edge ophthalmologic imaging to address ocular diseases such as glaucoma illustrates how the center will cultivate new possibilities across bioengineering and medicine.Building on these breakthroughs, the center will expand into diverse areas of translational science, encouraging broader collaborations that accelerate discovery and improve patient outcomes well beyond eye care.
More from Youtube
- 0:56Could Weight-Loss Drugs Curb Cravings for Addictive Substances? | Breakthroughs Can’t WaitEveryone has heard of Ozempic and Wegovy for treating diabetes and weight loss. But, what's been discovered in clinical trials, is an anti-craving effect is showing promising results for those battling alcohol and drug addiction.At the University of Maryland, Baltimore, researchers are exploring how GLP-1 receptor agonists — a class of drugs commonly used for weight loss — may offer new hope for people with cocaine use disorder. This is just one example of how federally funded research at UMB is Changing The Future Today.Hear from Sarah Kattakuzhy, MD, co-director for the Research Initiative on Infectious Disease and Substance Use Disorder, at the University of Maryland School of Medicine explains. Kattakuzhy is also the associate director of the Kahlert Institute for Addiction Medicine.🧪 Breakthroughs Can’t Wait: UMB research drives innovation, improves lives, and tackles global challenges. But we can’t do it without continued support.🔗 Learn more and support research that saves lives: https://www.umaryland.edu/breakthroughs #BreakthroughsCantWait #NIHfunding #CocaineUseDisorder #GLP1 #AddictionResearch #UMB #ResearchMatters
- 0:55Confronting the 4th Wave of the Drug Overdose Death Crisis | Breakthroughs Can't WaitOpioid and cocaine use epidemic is entrenched within Baltimore city, and there are no FDA-approved treatment for any stimulant disorders.At the University of Maryland, Baltimore, researchers are exploring how GLP-1 receptor agonists — a class of drugs commonly used for weight loss — may offer new hope for people with cocaine use disorder. This is just one example of how federally funded research at UMB is Changing The Future Today.Hear from Sarah Kattakuzhy, MD, co-director for the Research Initiative on Infectious Disease and Substance Use Disorder, at the University of Maryland School of Medicine explains. Kattakuzhy is also the associate director of the Kahlert Institute for Addiction Medicine.🧪 Breakthroughs Can’t Wait: UMB research drives innovation, improves lives, and tackles global challenges. But we can’t do it without continued support.🔗 Learn more and support research that saves lives: https://www.umaryland.edu/breakthroughs #BreakthroughsCantWait #NIHfunding #CocaineUseDisorder #GLP1 #AddictionResearch #UMB #ResearchMatters